PMID- 11894982 OWN - NLM STAT- MEDLINE DCOM- 20020326 LR - 20190813 IS - 0300-0664 (Print) IS - 0300-0664 (Linking) VI - 55 IP - 5 DP - 2001 Nov TI - Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. PG - 689-93 AB - Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant tumour syndrome. It is characterized by primary hyperparathyroidism, pituitary neoplasia and foregut lineage neuroendocrine neoplasia. Malignant thymic carcinoid tumours are an uncommon but important manifestation of MEN 1. Transcervical thymectomy is often advocated as prophylaxis against thymic carcinoids, although there is a paucity of evidence to support the efficacy of this procedure. This is the first report of a malignant thymic carcinoid occurring in an MEN 1 patient following prior parathyroidectomy and transcervical thymectomy. It is concluded that transcervical thymectomy does not reliably provide prophylaxis against thymic carcinoid. FAU - Burgess, J R AU - Burgess JR AD - Department of Diabetes, Royal Hobart Hospital, Tasmania, Australia. jburgess@postoffice.utas.edu.au FAU - Giles, N AU - Giles N FAU - Shepherd, J J AU - Shepherd JJ LA - eng PT - Case Reports PT - Journal Article PL - England TA - Clin Endocrinol (Oxf) JT - Clinical endocrinology JID - 0346653 RN - RWM8CCW8GP (Octreotide) SB - IM MH - Adolescent MH - Carcinoid Tumor/*prevention & control/surgery MH - Humans MH - Male MH - Multiple Endocrine Neoplasia Type 1/*surgery MH - Octreotide MH - Parathyroidectomy MH - *Thymectomy MH - Thymus Neoplasms/*prevention & control/surgery MH - Treatment Failure EDAT- 2002/03/16 10:00 MHDA- 2002/03/27 10:01 CRDT- 2002/03/16 10:00 PHST- 2002/03/16 10:00 [pubmed] PHST- 2002/03/27 10:01 [medline] PHST- 2002/03/16 10:00 [entrez] AID - 1348 [pii] AID - 10.1046/j.1365-2265.2001.01348.x [doi] PST - ppublish SO - Clin Endocrinol (Oxf). 2001 Nov;55(5):689-93. doi: 10.1046/j.1365-2265.2001.01348.x.